Patient Buzz: Eyelid Ptosis from Botulinum Toxin Injections
Several media outlets have covered the case of a popular blogger who recently experienced eyelid ptosis from botulinum toxin injections. How can dermatologists avoid adverse effects when injecting botulinum toxin?
For an expert opinion I contacted Dallas dermatologist Elizabeth Bahar Houshmand, MD, FAAD.
What does the scientific literature say about the frequency of eyelid ptosis as an adv …
Several media outlets have covered the case of a popular blogger who recently experienced eyelid ptosis from botulinum toxin injections. How can dermatologists avoid adverse effects when injecting botulinum toxin?
For an expert opinion I contacted Dallas dermatologist Elizabeth Bahar Houshmand, MD, FAAD.
What does the scientific literature say about the frequency of eyelid ptosis as an adv … Continue reading "Patient Buzz: Eyelid Ptosis from Botulinum Toxin Injections"
Is beauty really in the phi of the beholder? Are the faces that conform to the phi mask, that perfectly display the golden ratio of 1.618, really the most beautiful faces among us? Should we be seeking to help our patients approach a mathematical definition of beauty, or should we be seeking to preserve, enhance, and celebrate that which is unique and distinctive in their features, and forget the … 
Introduction
In aesthetic medicine, millennials have emerged as one of the leading patient demographics seeking minimally invasive cosmetic procedures.1-3 Millennials, defined as the generation of individuals born between 1981 and 1996, have surpassed baby boomers as the largest living generation in the United States.4,5 Extending between the ages of 23 and 39, this group is comprised of indivi … 
Glamour recently posted an article on the rise of the "Botox Bar.” These aesthetics bars offer injectables in a consumer-friendly manner reminiscent of upscale nail salons and blowout bars. How should dermatologists respond?
For an expert opinion, I consulted Heidi A. Waldorf, MD, associate clinical professor of dermatology, Icahn School of Medicine at Mount Sinai, New York. Dr. Waldorf is … 
Abstract
Botulinum toxin type A (BTA) is a neurotoxic protein that prevents the release of neurotransmitters from presynaptic nerves and has shown promise in treating neuropathic pain. Recently, BTA has been used to treat painful keloids and scars. We present a patient with refractory neuropathic pain in a normotrophic spread-scar treated with the injection of BTA.
A 47-year-old Caucasian female …